Bayer | BAYN - Market Capitalization


Bayer reported EUR49.13B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Air Liquide EUR 110.58B 17.86B Jun/2026
Akzo Nobel EUR 10.15B 1.73B Jun/2026
Alcon AG USD 37.06B 5.98B Mar/2026
Amarin USD 290M 51M Dec/2025
Arkema EUR 4.19B 239.59M Jun/2026
AstraZeneca USD 178.16B 111.83B Aug/2026
BASF EUR 41.75B 5.02B Jun/2026
Bayer EUR 49.51B 10.82B Aug/2026
Beiersdorf EUR 22.73B 3.43B Dec/2025
Corteva USD 56.64B 443M Jun/2026
Covestro EUR 12.54B 1.53B Dec/2025
Essilor EUR 76.16B 48.88B Jun/2026
Fresenius EUR 26.24B 3.72B Aug/2026
Fresenius Medical Care EUR 11.32B 642.58M Mar/2026
Genmab DKK 20.48B 1.02B Dec/2025
Givaudan CHF 29.05B 6.42B Dec/2025
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
GRIFOLS EUR 4.25B 1.16B Aug/2026
Henkel EUR 29.28B 1.43B Dec/2025
Hikma Pharmaceutical USD 3.49B 1.14B Aug/2026
Linde USD 200.18B 1.08B Mar/2026
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 46.78B 6.52B Mar/2026
Novartis USD 240.59B 67.17B Jun/2026
Nutrien USD 46.13B 9.82B Aug/2026
Philips EUR 23.09B 615.44M Jun/2026
PPG Industries USD 26.01B 948M Aug/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
SAP EUR 164.62B 15.85B Jun/2026
Solvay EUR 2.76B 8.17M Aug/2026
UCB EUR 46.41B 13.94B Dec/2025
Vinci EUR 71.82B 3.06B Aug/2026